← Back to all trials
Recruiting
NCT05685966
Retrospective Study of COVID-19 on Reproductive Function
Conditions: COVID-19
Sex: All
Ages: 20 Years – 42 Years
Enrollment: 400
Sponsor: Jinling Hospital, China
Location: China
Summary
This multi-center, retrospective cohort study aimed to determine which factors are associated with ongoing pregnancy rates in infertile patients received ART treatments during the current outbreak of COVID-19 infection.Couples who underwent IVF-ET/ICSI-ET/FET due to infertility in the department of Reproductive Medicine from 2022-11-23 to 2023-01-07 were included.
Patients who were infected with Coronavirus were observation groups; the infection status and clinical outcome were tracked.
Patients who were not infected with Coronavirus were control groups.
Eligibility Criteria
Inclusion Criteria:Diagnosed with infertilityPatients with IVF-ET/ICSI-ET/FET from 2022/11/23 to 2023/01/07Exclusion Criteria:Patients with contraindications to pregnancy or assisted reproductive technology
Source: ClinicalTrials.gov (NCT05685966). StuddyBuddy aggregates publicly available trial information.
